4-methyl-3-methylsulfonyl-5-phenyl-4h-1,2,4-triazole has been researched along with Seizures in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalton, CR; Dudley, MW; Kane, JM; Kehne, JH; Ketteler, HJ; McCloskey, TC; Miller, FP; Ogden, AM; Senyah, Y; Staeger, MA | 1 |
| Abdallah, A; Braun, DL; Chaney, SF; Dudley, MW; Kane, JM; Kehne, JH; Ketteler, HJ; Miller, FP; Ogden, AM; Senyah, Y | 1 |
2 other study(ies) available for 4-methyl-3-methylsulfonyl-5-phenyl-4h-1,2,4-triazole and Seizures
| Article | Year |
|---|---|
5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents.
Topics: Animals; Anticonvulsants; Cerebellum; Cerebral Cortex; Chlorides; Electroshock; Flumazenil; Male; Mice; Molecular Structure; Muscle Spasticity; Paralysis; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship; Strychnine; Triazoles | 1994 |
MDL 27,531 selectively reverses strychnine-induced seizures in mice.
Topics: Administration, Oral; Animals; Electric Stimulation; Hypnotics and Sedatives; Injections, Intraperitoneal; Male; Mice; Receptors, Glycine; Receptors, Neurotransmitter; Seizures; Strychnine; Triazoles | 1992 |